Thursday, March 28, 2024
HomeHyderabadDespite being a performing state, the Centre was actually punishing Telangana: KTR

Despite being a performing state, the Centre was actually punishing Telangana: KTR

If all Indian states grew at the same rate as Telangana, India would have achieved the targeted $5 trillion economy by 2022. Despite being a performing State, the Centre was actually punishing Telangana by not supporting it in its growth, said IT and Industries Minister KT Rama Rao.

Speaking at the annual CII event on ‘Beyond India@75 – Accelerating Telangana Growth Momentum – Resilience through Competitiveness, Innovation, Entrepreneurship, Sustainability,’ he stated that the Centre did not support the Hyderabad PharmaCity, which will be the world’s largest pharma manufacturing cluster.

A bulk drugs manufacturing cluster, other manufacturing clusters, industrial corridors, and other opportunities have also been denied to the state. Despite the fact that a special incentive was promised in the AP Reorganisation Act, nothing has been provided to both the Telugu States of Telangana and Andhra Pradesh, he said.

While India was a democratic country, not all states are treated equally. Each state is unique, and that uniqueness should be respected. Political affiliations should not determine whether or not a state is supported, Rama Rao said, urging the Centre to provide incentives to performing states. “Who are we to tell people what to eat, what to wear,” he said.

While initiatives like ‘Make in India’ are admirable, they have yet to move beyond slogans. The Minister said the Centre should empower and incentivize performing states. Despite import costs, distance, and other factors, many people believe that importing from China is cheaper than manufacturing locally. “We need to ask ourselves why making in China is cheaper, ask about our duty structures, about the road blocks to achieving scale and efficiency,” Rama Rao said.

ALSO READ: 7,000 Telangana students studying abroad on overseas scholarship scheme: KTR

Telangana has set a target of increasing the value of the lifesciences sector to around $250 billion by 2030, more than tripling the current $80 billion. The government now produces 35% (nearly nine billion doses) of all vaccines made globally. By the end of next year, this number will increase to 50 billion (14 billion doses).

Telangana also has 214 USFDA approved manufacturing facilities, the highest in the world, Rama Rao said adding that Telangana is expanding the Genome Valley and Medical Devices Park further. The PharmaCity has potential to create employment opportunities to five lakh people.

 

 

 

 

 

(This story has been sourced from a third-party syndicated feed, agencies. Raavi Media accepts no responsibility or liability for the text’s dependability, trustworthiness, reliability, and data. Raavi Media management/ythisnews.com reserves the sole right to alter, delete or remove (without notice) the content at its absolute discretion for any reason whatsoever.)